|
|
Synthesis and Self-Assembling NanoMicelles of Phosphatidyl Polyethyleneglycol Monomethyl Ether |
Institute of Biomedical Engineering, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin Key Laboratory of Biomedical Materials, Tianjin 300192, China |
|
|
Abstract A series of phosphatidyl polyethyleneglycol monomethyl ether nanomicelles were synthesized by benzyl protecting, hydrogenation reduction and esterification using glycerol as raw material. The micelles were prepared by solvent evaporation method, and characterized and analized by fluorescent probe, scanning electron microscopy, transmission electron microscopy, Zeta PALSsubmicron size and potential analyzer. Experimental results showed that the mPEG-lipids formed spherical micelles with coreshell structure and an average diameter of 100~200 nm, and the CMC of nano-micelles were 10-6mol/L. Compared to conventional small molecules surfactant, mPEGlipids micelles have better stability in water due to the lower CMC. Ambient effect such as salt, glucose exerts a strong influence on the stability of the micelles. And these influence is tightly correlated to their concentration. Due to their stable structure, phosphatidyl polyethyleneglycol monomethyl ether nano-micelles have promise of being applied as nano carriers for drugs.
|
|
|
|
|
[1]Mero A, Schiavon O, Pasut G, et al. A biodegradable polymeric carrier based on PEG for drug delivery [J]. Journal of Bioactive and Compatible Polymers 2009, 24(3), 220-234.
[2]Reddy PD, Swarnalatha D. Recent advances in novel Drug delivery systems[J].Int J Pharm Tech Research, 2010, 2(3), 2025-2027.
[3]Senior J, Delgado C, Fisher D, et al. Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)coated vesicles[J]. Biochim Biophys Acta, 1991,1062: 77-82.
[4]Allen TM, Hansen C, Martin F, et al. A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation halflives in vivo[J]. Biochim Biophys Acta, 1991, 1066: 29-36.
[5]Santos ND, Allen C, Doppen AM, et al. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding[J]. Biochimi Biophys Acta (BBA)Biomembranes, 2007, 1768(6):1367-1377.
[6]Lim SB, Rubinstein I, nyüksel H. Freeze drying of peptide drugs selfassociated with longcirculating, biocompatible and biodegradable sterically stabilized phospholipid nanomicelles[J]. 2008, 356(1-2): 345-350.
[7]Huang SK, Lee KD, Hong K, et al. Microscopic localization of sterically stabilized liposomes in colon carcinomabearing mice[J]. Cancer Res, 1992, 52: 5135-5143.
[8]Wu NZ, Da D, Rudoll TL, et al. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue[J]. Cancer Res, 1993, 53:3765-3770.
[9]Torchilin VP, Lukyanov AN, Gao ZG, et al. Polymeric micelles as targetable pharmaceutical carriers[M] // CarrierBased Drug Delivery,ACS Symposium Series. Washington DC: ACS Publication, 2004: 120-129.
[10]Lukyanov AN, Gao ZG, Torchilin VP. Micelles from polyethylene glycol/phosph atidylethanol amine conjugates for tumor drug delivery[J]. J Control Release,2003, 91: 97-102.
[11]Sears BD. Synthetic Phospholipid Compounds[P]. United States Patent: 4534899, 1985.
[12]Lindberg J, Ekeroth J, Konradsson P. Efficient synthesis of phospholipids from glycidyl phosphates[J]. J Org Chem, 2002, 67(1): 194-199.
[13]Alcaraz ML, Peng L, Klotz P, et al. Synthesis and properties of photoactivatable phospholipid derivatives designed to probe the membraneassociate domains of proteins[J]. J Org Chem, 1996, 61(1): 192-201.
[14]Torchilin VP, Levchenko TS, Lukyanov AN, et al. pNitrophenylcarbonyl PEGPEliposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via pnitrophenylcarbonyl groups[J]. Biochim Biophys Acta, 2001, 1511: 397-411.
[15]Lundberg BB, Mortimer BC, Redgrave TG. Submicron lipid emulsions containing amphipathic polyethylene glycol for use as drugcarriers with prolonged circulation time[J]. Int J Pharm, 1996, 134: 119-127.
[16]Kim IS, Kim SH. Evaluation of polymeric nanoparticles composed of cholic acid and methoxypoly(ethylene glycol) [J]. Int J Pharm, 2001, 226: 23-29.
|
|
|
|